257
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 333-344 | Received 29 Mar 2022, Accepted 12 Sep 2022, Published online: 25 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sophie Köhne, Thomas Hillemacher, Alexander Glahn & Patrick Bach. (2024) Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. Expert Opinion on Emerging Drugs 0:0, pages 1-14.
Read now
Anny Gano, Terrence Deak & Ricardo Marcos Pautassi. (2023) A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse. The American Journal of Drug and Alcohol Abuse 49:3, pages 269-282.
Read now

Articles from other publishers (2)

Erica N. Grodin. (2024) Neuroimmune modulators as novel pharmacotherapies for substance use disorders. Brain, Behavior, & Immunity - Health 36, pages 100744.
Crossref
Mustafa K. Mushatet, Thikra abd jary, Asaad Abbas khalaf & Mustafa Abbas Alqabbany. (2023) Protective Effect of Prosopis Farcta Fruit Aqueous Extract Against Oxidative Stress Caused By Ethanol in Albino Rats. Biomedical and Pharmacology Journal 16:4, pages 2521-2530.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.